Our vision: "Cancer treatment in one dose." OncoSynergy is a patient-focused biotechnology startup spun out from UCSF and the JLABS South San Francisco incubator. Based in bustling Stamford, Connecticut (~40 mins from NYC), we are creating a new class of cancer medicines to maximize patient survival and quality of life with minimal side effects. We are a small, nimble startup team that launched our first clinical trial in 2020 for glioblastoma (aggressive brain cancer). While we are at the forefront of potential game changing research, please support our patients. They need you to spread awareness far and wide so that more research is being dedicated to devastating cancers like glioblastoma.
View Top Employees from OncoSynergyWebsite | http://www.oncosynergy.com/ |
Revenue | $811000 |
Employees | 5 (5 on RocketReach) |
Founded | 2011 |
Phone | (415) 299-4249 |
Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Medical Device, Therapeutics |
Web Rank | 27 Million |
Keywords | Mpp14 Binding Site Hsp90 |
Competitors | Aptahem, MGB Biopharma Limited, Neurimmune AG, Protalex, Inc., Quince Therapeutics |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular OncoSynergy employee's phone or email?
The OncoSynergy annual revenue was $811000 in 2024.
Anne-Marie Carbonell is the Co-Founder, Chief Executive Officer, Chief Medical Officer of OncoSynergy.
5 people are employed at OncoSynergy.
OncoSynergy is based in Stamford, Connecticut.
The NAICS codes for OncoSynergy are [541, 541714, 5417, 54, 54171].
The SIC codes for OncoSynergy are [873, 87].